Pathogenesis of thyroid eye disease: review and update on molecular mechanisms
- PMID:26567024
- DOI: 10.1136/bjophthalmol-2015-307399
Pathogenesis of thyroid eye disease: review and update on molecular mechanisms
Abstract
Orbital changes in thyroid orbitopathy (TO) result from de novo adipogenesis, hyaluronan synthesis, interstitial oedema and enlargement of extraocular muscles. Cellular immunity, with predominantly CD4+ T cells expressing Th1 cytokines, and overexpression of macrophage-derived cytokines, perpetuate orbital inflammation. Orbital fibroblasts appear to be the major effector cells. Orbital fibroblasts express both thyrotropin receptor (TSHR) and insulin-like growth factor-1 receptor (IGF-1R) at higher levels than normal fibroblasts. TSHR expression increases in adipogenesis; TSHR agonism enhances hyaluronan production. IGF-1R stimulation leads to adipogenesis, hyaluronan synthesis and production of the chemokines, interleukin (IL)-16 and Regulated on Activation, Normal T Cell Expression and Secreted, which facilitate lymphocyte trafficking into the orbit. Immune activation uses a specific CD40:CD154 molecular bridge to activate orbital fibroblasts, which secrete pro-inflammatory cytokines including IL-1β, IL-1α, IL-6, IL-8, macrophage chemoattractant protein-1 and transforming growth factor-β, to perpetuate orbital inflammation. Molecular pathways including adenylyl cyclase/cyclic adenosine monophosphate, phophoinositide 3 kinase/AKT/mammalian target of rapamycin, mitogen-activated protein kinase are involved in TO. The emergence of a TO animal model and a new generation of TSHR antibody assays increasingly point towards TSHR as the primary autoantigen for extrathyroidal orbital involvement. Oxidative stress in TO resulting from imbalances of the oxidation-reduction state provides a framework of understanding for smoking prevention, achieving euthyroidism and the use of antioxidants such as selenium. Progress has been made in the understanding of the pathogenesis of TO, which should advance development of novel therapies targeting cellular immunity, specifically the CD40:CD40 ligand interaction, antibody-producing B cells, cytokines, TSHR and IGF-1R and its signalling pathways. Further studies in signalling networks and molecular triggers leading to burnout of TO will further our understanding of TO.
Keywords: Immunology; Inflammation; Orbit; Treatment Medical.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Similar articles
- Pathogenesis of ophthalmopathy in autoimmune thyroid disease.Heufelder AE.Heufelder AE.Rev Endocr Metab Disord. 2000 Jan;1(1-2):87-95. doi: 10.1023/a:1010020621687.Rev Endocr Metab Disord. 2000.PMID:11704996Review.
- Cutting edge: retrobulbar inflammation, adipogenesis, and acute orbital congestion in a preclinical female mouse model of Graves' orbitopathy induced by thyrotropin receptor plasmid-in vivo electroporation.Moshkelgosha S, So PW, Deasy N, Diaz-Cano S, Banga JP.Moshkelgosha S, et al.Endocrinology. 2013 Sep;154(9):3008-15. doi: 10.1210/en.2013-1576. Epub 2013 Jul 30.Endocrinology. 2013.PMID:23900776
- Pathogenic Phenotype of Adipogenesis and Hyaluronan in Orbital Fibroblasts From Female Graves' Orbitopathy Mouse Model.Görtz GE, Moshkelgosha S, Jesenek C, Edelmann B, Horstmann M, Banga JP, Eckstein A, Berchner-Pfannschmidt U.Görtz GE, et al.Endocrinology. 2016 Oct;157(10):3771-3778. doi: 10.1210/en.2016-1304. Epub 2016 Aug 23.Endocrinology. 2016.PMID:27552248
- Effects of thyrotropin and thyrotropin-receptor-stimulating Graves' disease immunoglobulin G on cyclic adenosine monophosphate and hyaluronan production in nondifferentiated orbital fibroblasts of Graves' ophthalmopathy patients.van Zeijl CJ, Fliers E, van Koppen CJ, Surovtseva OV, de Gooyer ME, Mourits MP, Wiersinga WM, Miltenburg AM, Boelen A.van Zeijl CJ, et al.Thyroid. 2010 May;20(5):535-44. doi: 10.1089/thy.2009.0447.Thyroid. 2010.PMID:20384487
- Current Insights into the Pathogenesis of Graves' Ophthalmopathy.Bahn RS.Bahn RS.Horm Metab Res. 2015 Sep;47(10):773-8. doi: 10.1055/s-0035-1555762. Epub 2015 Sep 11.Horm Metab Res. 2015.PMID:26361262Review.
Cited by
- Transnasal endoscopic orbital inner wall decompression combined with penetrating keratoplasty for corneal ulcer perforation in Graves' ophthalmopathy: A case report.Wang P, Han Z, Li X, Lin R, Yuan H.Wang P, et al.Medicine (Baltimore). 2024 Oct 4;103(40):e39653. doi: 10.1097/MD.0000000000039653.Medicine (Baltimore). 2024.PMID:39465749Free PMC article.
- Is there a role for insulin-like growth factor inhibition in the treatment of COVID-19-related adult respiratory distress syndrome?Winn BJ.Winn BJ.Med Hypotheses. 2020 Nov;144:110167. doi: 10.1016/j.mehy.2020.110167. Epub 2020 Aug 7.Med Hypotheses. 2020.PMID:32795835Free PMC article.
- Repurposing Lenvatinib as A Potential Therapeutic Agent against Thyroid Eye Disease by Suppressing Adipogenesis in Orbital Adipose Tissues.Cheng L, Hu J, Zhang L, Shen N, Chen H, Zhang F.Cheng L, et al.Pharmaceuticals (Basel). 2022 Oct 22;15(11):1305. doi: 10.3390/ph15111305.Pharmaceuticals (Basel). 2022.PMID:36355477Free PMC article.
- Correlation between Peripheral T Cell Subsets and the Activity of Thyroid-Associated Ophthalmopathy.Hu H, Liang L, Ge Q, Jiang X, Fu Z, Liu C, Long J.Hu H, et al.Int J Endocrinol. 2022 Mar 8;2022:2705650. doi: 10.1155/2022/2705650. eCollection 2022.Int J Endocrinol. 2022.PMID:35311030Free PMC article.
- The Role of Oxidative Stress and Therapeutic Potential of Antioxidants in Graves' Ophthalmopathy.Hou TY, Wu SB, Kau HC, Tsai CC.Hou TY, et al.Biomedicines. 2021 Dec 10;9(12):1871. doi: 10.3390/biomedicines9121871.Biomedicines. 2021.PMID:34944687Free PMC article.Review.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous